A new study has identified a set of plasma proteins that can predict whether patients with triple-negative breast cancer (TNBC) will respond to immunotherapy. By analyzing blood samples from 195 TNBC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results